WFCT Logo Published on March 16, 2021 in TINT: A phase II study of trametinib in paediatric, adolescent and young adult patients with Neurofibromatosis type 1 associated plexiform neurofibromas or progressive optic pathway gliomas. Full resolution (1500 × 796)